Therefore we tested whether plasma levels of vaspin are related to the clinical manifestation of ISR in patient with stable coronary artery disease that have received an DES and if vaspin inhibits the migration of smooth muscle cells and endothelial cells in vitro. The gene discussed is SERPINA12; the disease is coronary artery disorder.